UroGen Pharma URGN
NASDAQ URGN
$40.63 +0.18 (+0.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Finished Goods (2020 - 2021)

Updated

UroGen Pharma (URGN) reported Finished Goods of $888,000 for Q1 2021, down 2.7% from the prior quarter.

Analysis

UroGen Pharma (URGN) Finished Goods (2020 - 2021) Analysis & Trends

At the end of FY2020, UroGen Pharma posted Finished Goods of $913,000.

  • Five-year quarterly Finished Goods spans a low of $232,000 in Q2 2020 and a high of $913,000 in Q4 2020.
  • Per Business Quant data, the three quarters before Q1 2021 came in at $913,000 (Q4 2020), $419,000 (Q3 2020) and $232,000 (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 UroGen Pharma 1.99 Bn 1.49 Bn 65.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 888,000.00
Dec 31, 2020 913,000.00
Sep 30, 2020 419,000.00
Jun 30, 2020 232,000.00
API Access

UroGen Pharma Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=URGN&period=max&api_key=YOUR_API_KEY